These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27217402)

  • 1. Angiotensin-Converting Enzyme 2 Metabolizes and Partially Inactivates Pyr-Apelin-13 and Apelin-17: Physiological Effects in the Cardiovascular System.
    Wang W; McKinnie SM; Farhan M; Paul M; McDonald T; McLean B; Llorens-Cortes C; Hazra S; Murray AG; Vederas JC; Oudit GY
    Hypertension; 2016 Aug; 68(2):365-77. PubMed ID: 27217402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apelin is a positive regulator of ACE2 in failing hearts.
    Sato T; Suzuki T; Watanabe H; Kadowaki A; Fukamizu A; Liu PP; Kimura A; Ito H; Penninger JM; Imai Y; Kuba K
    J Clin Invest; 2013 Dec; 123(12):5203-11. PubMed ID: 24177423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogues.
    Wang W; McKinnie SM; Patel VB; Haddad G; Wang Z; Zhabyeyev P; Das SK; Basu R; McLean B; Kandalam V; Penninger JM; Kassiri Z; Vederas JC; Murray AG; Oudit GY
    J Am Heart Assoc; 2013 Jul; 2(4):e000249. PubMed ID: 23817469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apelin and ACE2 in cardiovascular disease.
    Kalea AZ; Batlle D
    Curr Opin Investig Drugs; 2010 Mar; 11(3):273-82. PubMed ID: 20178040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolyl Carboxypeptidase Mediates the C-Terminal Cleavage of (Pyr)-Apelin-13 in Human Umbilical Vein and Aortic Endothelial Cells.
    De Hert E; Bracke A; Pintelon I; Janssens E; Lambeir AM; Van Der Veken P; De Meester I
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogs.
    Wang W; Shen M; Fischer C; Basu R; Hazra S; Couvineau P; Paul M; Wang F; Toth S; Mix DS; Poglitsch M; Gerard NP; Bouvier M; Vederas JC; Penninger JM; Kassiri Z; Oudit GY
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):13006-13015. PubMed ID: 31189595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between the apelinergic system and ACE2 in the cardiovascular system: therapeutic implications.
    Chatterjee P; Gheblawi M; Wang K; Vu J; Kondaiah P; Oudit GY
    Clin Sci (Lond); 2020 Sep; 134(17):2319-2336. PubMed ID: 32901821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
    Azizi Y; Faghihi M; Imani A; Roghani M; Zekri A; Mobasheri MB; Rastgar T; Moghimian M
    Eur J Pharmacol; 2015 Aug; 761():101-8. PubMed ID: 25936512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.
    Patel VB; Clarke N; Wang Z; Fan D; Parajuli N; Basu R; Putko B; Kassiri Z; Turner AJ; Oudit GY
    J Mol Cell Cardiol; 2014 Jan; 66():167-76. PubMed ID: 24332999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pyr
    Yang P; Kuc RE; Brame AL; Dyson A; Singer M; Glen RC; Cheriyan J; Wilkinson IB; Davenport AP; Maguire JJ
    Front Neurosci; 2017; 11():92. PubMed ID: 28293165
    [No Abstract]   [Full Text] [Related]  

  • 11. The Metalloprotease Neprilysin Degrades and Inactivates Apelin Peptides.
    McKinnie SM; Fischer C; Tran KM; Wang W; Mosquera F; Oudit GY; Vederas JC
    Chembiochem; 2016 Aug; 17(16):1495-8. PubMed ID: 27377680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury.
    Simpkin JC; Yellon DM; Davidson SM; Lim SY; Wynne AM; Smith CC
    Basic Res Cardiol; 2007 Nov; 102(6):518-28. PubMed ID: 17694254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking (Pyr)
    Onorato JM; Xu C; Chen XQ; Rose AV; Generaux C; Lentz K; Shipkova P; Arthur S; Hennan JK; Haskell R; Myers MC; Lawrence RM; Finlay HJ; Basso M; Bostwick J; Fernando G; Garcia R; Hellings S; Hsu MY; Zhang R; Zhao L; Gargalovic P
    Anal Biochem; 2019 Mar; 568():41-50. PubMed ID: 30605634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac action of the first G protein biased small molecule apelin agonist.
    Read C; Fitzpatrick CM; Yang P; Kuc RE; Maguire JJ; Glen RC; Foster RE; Davenport AP
    Biochem Pharmacol; 2016 Sep; 116():63-72. PubMed ID: 27475715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges.
    Kazemi-Bajestani SM; Patel VB; Wang W; Oudit GY
    Cardiol Res Pract; 2012; 2012():823193. PubMed ID: 22655211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE2 and the Homolog Collectrin in the Modulation of Nitric Oxide and Oxidative Stress in Blood Pressure Homeostasis and Vascular Injury.
    Yang G; Chu PL; Rump LC; Le TH; Stegbauer J
    Antioxid Redox Signal; 2017 Apr; 26(12):645-659. PubMed ID: 27889958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease.
    Maguire JJ; Kleinz MJ; Pitkin SL; Davenport AP
    Hypertension; 2009 Sep; 54(3):598-604. PubMed ID: 19597036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases.
    Kuba K; Imai Y; Penninger JM
    Circ J; 2013; 77(2):301-8. PubMed ID: 23328447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of apelin-apelin receptor system in postischaemic myocardial protection: a pharmacological postconditioning tool?
    Rastaldo R; Cappello S; Folino A; Losano G
    Antioxid Redox Signal; 2011 Mar; 14(5):909-22. PubMed ID: 20615122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained cardiovascular actions of APJ agonism during renin-angiotensin system activation and in patients with heart failure.
    Barnes GD; Alam S; Carter G; Pedersen CM; Lee KM; Hubbard TJ; Veitch S; Jeong H; White A; Cruden NL; Huson L; Japp AG; Newby DE
    Circ Heart Fail; 2013 May; 6(3):482-91. PubMed ID: 23519586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.